Answer
Aug 08, 2025 - 10:08 AM
CagriSema is administered as a once-weekly subcutaneous injection. This method ensures consistent delivery of the medication, crucial for maintaining therapeutic levels and improving adherence to treatment, especially for individuals managing chronic conditions like obesity and diabetes.
